Unternehmen in BERLIN

ALACRIS THERANOSTICS GMBH

BeobachtenFeed abonnierenFörderungen als CSV

In 0 Bekanntmachungen genannt, seit 1. Januar 2013, aber in keiner als Auftragnehmer eines Zuschlags.

Fördermittel

Kohesio und Finanztransparenzsystem der EU, so gezählt.

8 Förderungen, zusammen 6,7 Mio. €.

QuelleBetragFörderungen
EU-Haushalt (Finanztransparenzsystem)6,7 Mio. €88
JahrProgrammProjektBetrag und Beleg
2018EU Budget - European CommissionCNECT - Directorate-General for Communications Networks, Content and Technology826121 - IPC - INDIVIDUALIZEDPAEDIATRICCURE: CLOUD-BASED VIRTUAL-PATIENT MODELS FOR PRECISION PAEDIATRIC ONCOLOGY826121 - IPC - INDIVIDUALIZEDPAEDIATRICCURE: CLOUD-BASED VIRTUAL-PATIENT MODELS FOR PRECISION PAEDIATRIC ONCOLOGY861.439 €Mittelbindung
2017EU Budget - European CommissionREA - European Research Executive Agency766118 - TAPAS - TARGETING PLATELET ADHESION RECEPTORS IN THROMBOSIS766118 - TAPAS - TARGETING PLATELET ADHESION RECEPTORS IN THROMBOSIS249.221 €Mittelbindung
2016EU Budget - European CommissionRTD - Directorate-General for Research and Innovation686282 - CANPATHPRO - GENERATION OF THE CANPATH PROTOTYPE - A PLATFORM FOR PREDICTIVE CANCER PATHWAY MODELING686282 - CANPATHPRO - GENERATION OF THE CANPATH PROTOTYPE - A PLATFORM FOR PREDICTIVE CANCER PATHWAY MODELING225.653 €Mittelbindung
2016EU Budget - European CommissionRTD - Directorate-General for Research and Innovation686282 - CANPATHPRO - GENERATION OF THE CANPATH PROTOTYPE - A PLATFORM FOR PREDICTIVE CANCER PATHWAY MODELING686282 - CANPATHPRO - GENERATION OF THE CANPATH PROTOTYPE - A PLATFORM FOR PREDICTIVE CANCER PATHWAY MODELING3.198.218 €Mittelbindung
2015EU Budget - European CommissionREA - European Research Executive Agency687089 - PROSEQO - PROTEIN SEQUENCING USING OPTICAL SINGLE MOLECULE REAL-TIME DETECTION687089 - PROSEQO - PROTEIN SEQUENCING USING OPTICAL SINGLE MOLECULE REAL-TIME DETECTION374.625 €Mittelbindung
2015EU Budget - European CommissionCNECT - Directorate-General for Communications Networks, Content and Technology689068 - SMARTOOL - SIMULATION MODELING OF CORONARY ARTERY DISEASE: A TOOL FOR CLINICAL DECISION SUPPORT689068 - SMARTOOL - SIMULATION MODELING OF CORONARY ARTERY DISEASE: A TOOL FOR CLINICAL DECISION SUPPORT811.375 €Mittelbindung
2014EU Budget - European CommissionRTD - Directorate-General for Research and Innovation643776 - TREGeneration - Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes643776 - TREGeneration - Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes277.500 €Mittelbindung
2013EU Budget - European CommissionRTD - Directorate-General for Research and InnovationSYBILSYBIL666.516 €Mittelbindung

Angaben aus den Bekanntmachungen

0 Nennungen seit 1. Januar 2013, zuletzt am 1. Januar 2013, dieser Organisation zugeordnet. Wie wir zuordnen

Anschrift
FABECKSTRASSE 60-62, 14195 BERLIN
USt-IdNr.
DE269447706
Schreibweisen
  • ALACRIS THERANOSTICS GMBH